title: Iodine contrast media doses equal-attenuating with gadolinium chelates at CT-aortography may have less risk of contrast-induced nephropathy and no risk of nephrogenic systemic fibrosis in azotaemic patients!
authors.forename: Ulf
authors.initials: U
authors.lastname: Nyman
authors.forename: Barbara
authors.initials: B
authors.lastname: Elmståhl
authors.forename: Peter
authors.initials: P
authors.lastname: Leander
authors.forename: Torsten
authors.initials: T
authors.lastname: Almén
mesh_terms: D001018:Aortic Diseases / Q000000981:diagnostic imaging*; D001027:Aortography / Q000379:methods*; D053099:Azotemia / Q000000981:diagnostic imaging*; D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects; D003404:Creatinine / Q000097:blood; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007090:Image Interpretation, Computer-Assisted; D007455:Iodine / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D054989:Nephrogenic Fibrosing Dermopathy / Q000139:chemically induced* / Q000517:prevention & control; D009942:Organometallic Compounds / Q000009:adverse effects*; D018570:Risk Assessment; D014057:Tomography, X-Ray Computed
chemical_list: D003287:Contrast Media; D009942:Organometallic Compounds; C090600:gadobutrol; D007455:Iodine; D003404:Creatinine